Edition:
United States

Merrimack Pharmaceuticals Inc (MACK.OQ)

MACK.OQ on NASDAQ Stock Exchange Global Market

5.57USD
21 Sep 2018
Change (% chg)

$-0.08 (-1.42%)
Prev Close
$5.65
Open
$5.68
Day's High
$5.77
Day's Low
$5.57
Volume
44,997
Avg. Vol
47,230
52-wk High
$15.38
52-wk Low
$4.74

Select another date:

Mon, Jun 25 2018

Merrimack to scrap development of pancreatic cancer treatment

Merrimack Pharmaceuticals Inc said on Monday it would stop developing its experimental treatment for pancreatic cancer after it failed to meet the main and secondary goals in a mid-stage trial.

UPDATE 1-Merrimack to scrap development of pancreatic cancer treatment

June 25 Merrimack Pharmaceuticals Inc said on Monday it would stop developing its experimental treatment for pancreatic cancer after it failed to meet the main and secondary goals in a mid-stage trial.

Merrimack to scrap development of pancreatic cancer treatment

June 25 Merrimack Pharmaceuticals Inc said on Monday it would discontinue the development of an experimental treatment for pancreatic cancer after the drug failed to meet the main and secondary goals of a mid-stage trial.

BRIEF-Merrimack Pharmaceuticals Reports Q1 Operating Loss Per Share Of $1.33

* THREE CLINICAL READOUTS EXPECTED IN 2018, INCLUDING DATA FROM TWO RANDOMIZED PHASE 2 STUDIES

Select another date: